CAMBRIDGE BIOMEDICAL CAMPUS LTD

Active Cambridge

Research and experimental development on biotechnology

2 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
C

CAMBRIDGE BIOMEDICAL CAMPUS LTD

Research and experimental development on biotechnology

Founded 22 Jun 2021 Active Cambridge, United Kingdom 2 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 9 Feb 2026 Next due 31 Mar 2027 10 months remaining
Confirmation Submitted 27 Jun 2025 Next due 5 Jul 2026 1 month remaining
Net assets £598K £134K 2025 year on year
Total assets £2M £42K 2025 year on year
Total Liabilities £969K £175K 2025 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Addenbrookes Hospital Box 146 Cambridge Biomedical Campus Hills Road Cambridge CB2 0QQ United Kingdom

Email

info@example.com

Website

www.example.com

Full company profile for CAMBRIDGE BIOMEDICAL CAMPUS LTD (13471389), an active life sciences and medical technology company based in Cambridge, United Kingdom. Incorporated 22 Jun 2021. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2025
Type Total Exemption Full
Next accounts 31 December 2026
Due by 30 September 2027 9 months

Net Assets, Total Assets & Total Liabilities (2022–2025)

Cash in Bank

£251.49k

Decreased by £1.14M (-82%)

Net Assets

£598.41k

Decreased by £133.58k (-18%)

Total Liabilities

£969.41k

Increased by £175.30k (+22%)

Turnover

N/A

Employees

2

Decreased by 1 (-33%)

Debt Ratio

62%

Increased by 10 (+19%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
Dec Year End
2024
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

3 active
Status
Gillian Claire Louisa JohnsonDirectorBritishEngland5216 Sept 2024Active
Scott Thomas HaldaneDirectorBritishUnited Kingdom6622 Jun 2021Active
Shaun Francis GradyDirectorBritish,irishEngland6524 Mar 2025Active

Shareholders

Shareholders (0)

No shareholder data available

Persons with Significant Control

Persons with Significant Control (0)

No PSC information available

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
13 Apr 2026OfficersAppointment of Mr Peter Robert Denton as director on 1 Apr 2026
13 Apr 2026OfficersTermination of Laurel Claire Powers-Freeling as director on 1 Apr 2026
9 Feb 2026AccountsAnnual accounts made up to 30 Jun 2025
4 Feb 2026OfficersAppointment of Dr Catherine Walsh as director on 3 Feb 2026
4 Feb 2026OfficersTermination of Scott Thomas Haldane as director on 3 Feb 2026
13 Apr 2026 Officers

Appointment of Mr Peter Robert Denton as director on 1 Apr 2026

13 Apr 2026 Officers

Termination of Laurel Claire Powers-Freeling as director on 1 Apr 2026

9 Feb 2026 Accounts

Annual accounts made up to 30 Jun 2025

4 Feb 2026 Officers

Appointment of Dr Catherine Walsh as director on 3 Feb 2026

4 Feb 2026 Officers

Termination of Scott Thomas Haldane as director on 3 Feb 2026

Recent Activity

Latest Activity

Appointment of Mr Peter Robert Denton as director on 1 Apr 2026

1 months ago on 13 Apr 2026

Termination of Laurel Claire Powers-Freeling as director on 1 Apr 2026

1 months ago on 13 Apr 2026

Annual accounts made up to 30 Jun 2025

3 months ago on 9 Feb 2026

Appointment of Dr Catherine Walsh as director on 3 Feb 2026

3 months ago on 4 Feb 2026

Termination of Scott Thomas Haldane as director on 3 Feb 2026

3 months ago on 4 Feb 2026